Overview
CVS Health Corporation, based in the United States, operates as an integrated healthcare company primarily engaging in the pharmacy services and retail drugstore sectors. It offers a broad range of services including pharmacy benefit management, retail and long-term care pharmacy services, and healthcare services through its walk-in medical clinics. A notable element of CVS Health's strategic endeavor is its expansion into health insurance, exemplified by its acquisition of Aetna, one of the nation's leading diversified healthcare benefits companies. This move has substantially broadened its healthcare offering, reinforcing CVS's position in managing pharmaceutical costs and extending its healthcare delivery capabilities. CVS Health’s initiatives aim to improve access to quality care and deliver better health outcomes while managing costs effectively.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for CVS Health Corporation as of 30 June 2025 is 384,329.00 MM.
- The operating income for CVS Health Corporation as of 30 June 2025 is 9,340.00 MM.
- The net income for CVS Health Corporation as of 30 June 2025 is 4,531.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 384,329.00 | 9,340.00 | 4,531.00 |
| 2025-03-31 | 376,741.00 | 9,334.00 | 5,280.00 |
| 2024-12-31 | 370,656.00 | 8,019.00 | 4,614.00 |
| 2024-09-30 | 367,246.00 | 9,660.00 | 5,016.00 |
| 2024-06-30 | 361,855.00 | 11,650.00 | 7,190.00 |
| 2024-03-31 | 359,662.00 | 12,546.00 | 7,321.00 |
| 2023-12-31 | 356,623.00 | 14,073.00 | 8,344.00 |
| 2023-09-30 | 346,601.00 | 14,370.00 | 8,632.00 |
| 2023-06-30 | 338,072.00 | 14,469.00 | 2,965.00 |
| 2023-03-31 | 329,915.00 | 15,344.00 | 4,093.00 |
| 2022-12-31 | 321,629.00 | 15,742.00 | 4,311.00 |
| 2022-09-30 | 314,343.00 | 15,443.00 | 3,283.00 |
| 2022-06-30 | 306,933.00 | 15,128.00 | 8,287.00 |
| 2022-03-31 | 298,770.00 | 14,621.00 | 8,041.00 |
| 2021-12-31 | 290,912.00 | 14,157.00 | 8,001.00 |
| 2021-09-30 | 283,981.00 | 13,227.00 | 7,577.00 |
| 2021-06-30 | 277,285.00 | 13,063.00 | 7,203.00 |
| 2021-03-31 | 270,115.00 | 13,619.00 | 7,395.00 |
| 2020-12-31 | 267,908.00 | 13,663.00 | 7,179.00 |
| 2020-09-30 | 265,285.00 | 14,117.00 | 7,953.00 |
| 2020-06-30 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | 3.66 | 3.66 |
| 2024-09-30 | 3.96 | 3.95 |
| 2024-06-30 | 5.65 | 5.63 |
| 2024-03-31 | 5.72 | 5.71 |
| 2023-12-31 | 6.49 | 6.47 |
| 2023-09-30 | 6.69 | 6.66 |
| 2023-06-30 | 2.29 | 2.27 |
| 2023-03-31 | 3.14 | 3.12 |
| 2022-12-31 | 3.29 | 3.26 |
| 2022-09-30 | 2.50 | 2.47 |
| 2022-06-30 | 6.29 | 6.23 |
| 2022-03-31 | 6.10 | 6.04 |
| 2021-12-31 | 6.07 | 6.02 |
| 2021-09-30 | 5.76 | 5.73 |
| 2021-06-30 | 5.48 | 5.46 |
| 2021-03-31 | 5.64 | 5.62 |
| 2020-12-31 | 5.48 | 5.46 |
| 2020-09-30 | 6.08 | 6.05 |
| 2020-06-30 | 6.33 | 6.29 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for CVS Health Corporation as of 30 June 2025 is 7,568.00 MM.
- The cash from investing activities for CVS Health Corporation as of 30 June 2025 is -5,680.00 MM.
- The cash from financing activities for CVS Health Corporation as of 30 June 2025 is -2,683.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 7,568.00 | -5,680.00 | -2,683.00 |
| 2025-03-31 | 8,760.00 | -6,281.00 | -2,240.00 |
| 2024-12-31 | 9,107.00 | -7,613.00 | -1,135.00 |
| 2024-09-30 | 4,611.00 | -8,308.00 | -2,538.00 |
| 2024-06-30 | 8,072.00 | -5,732.00 | -3,647.00 |
| 2024-03-31 | 10,891.00 | -14,469.00 | -1,270.00 |
| 2023-12-31 | 13,426.00 | -20,889.00 | 2,683.00 |
| 2023-09-30 | 14,110.00 | -19,766.00 | 1,468.00 |
| 2023-06-30 | 20,517.00 | -19,800.00 | 947.00 |
| 2023-03-31 | 20,052.00 | -11,568.00 | -5,140.00 |
| 2022-12-31 | 16,177.00 | -5,047.00 | -10,516.00 |
| 2022-09-30 | 22,134.00 | -6,368.00 | -11,243.00 |
| 2022-06-30 | 18,532.00 | -6,410.00 | -9,955.00 |
| 2022-03-31 | 18,936.00 | -5,387.00 | -10,821.00 |
| 2021-12-31 | 18,265.00 | -5,261.00 | -11,356.00 |
| 2021-09-30 | 17,827.00 | -5,055.00 | -11,718.00 |
| 2021-06-30 | 14,180.00 | -5,578.00 | -15,905.00 |
| 2021-03-31 | 15,452.00 | -5,804.00 | -13,556.00 |
| 2020-12-31 | 15,865.00 | -5,534.00 | -7,696.00 |
| 2020-09-30 | 14,932.00 | -5,009.00 | -5,860.00 |
| 2020-06-30 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | |||
| 2020-09-30 | |||
| 2020-06-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 | ||
| 2020-09-30 | ||
| 2020-06-30 |
Management Effectiveness
- The roa for CVS Health Corporation as of 30 June 2025 is 0.02.
- The roe for CVS Health Corporation as of 30 June 2025 is 0.06.
- The roic for CVS Health Corporation as of 30 June 2025 is 0.03.
- The croic for CVS Health Corporation as of 30 June 2025 is 0.00.
- The ocroic for CVS Health Corporation as of 30 June 2025 is 0.06.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | 0.02 | 0.06 | 0.03 | 0.00 | 0.06 |
| 2025-03-31 | 0.02 | 0.07 | 0.03 | 0.00 | 0.06 |
| 2024-12-31 | 0.02 | 0.06 | 0.03 | -0.04 | 0.03 |
| 2024-09-30 | 0.03 | 0.07 | 0.04 | -0.01 | 0.05 |
| 2024-06-30 | 0.03 | 0.10 | 0.05 | -0.03 | 0.07 |
| 2024-03-31 | 0.04 | 0.12 | 0.05 | -0.03 | 0.09 |
| 2023-12-31 | 0.04 | 0.12 | 0.05 | -0.03 | 0.09 |
| 2023-09-30 | 0.01 | 0.04 | 0.02 | 0.01 | 0.13 |
| 2023-06-30 | 0.02 | 0.04 | 0.02 | 0.01 | 0.14 |
| 2023-03-31 | 0.02 | 0.05 | 0.03 | 0.02 | 0.14 |
| 2022-12-31 | 0.01 | 0.04 | 0.02 | 0.03 | 0.16 |
| 2022-09-30 | 0.03 | 0.04 | 0.02 | 0.03 | 0.15 |
| 2022-06-30 | 0.03 | 0.11 | 0.05 | 0.01 | 0.12 |
| 2022-03-31 | 0.03 | 0.11 | 0.05 | 0.02 | 0.13 |
| 2021-12-31 | 0.03 | 0.11 | 0.05 | 0.01 | 0.12 |
| 2021-09-30 | 0.03 | 0.11 | 0.05 | 0.00 | 0.09 |
| 2021-06-30 | 0.03 | 0.11 | 0.05 | -0.05 | 0.09 |
| 2021-03-31 | 0.03 | 0.11 | 0.05 | -0.03 | 0.10 |
| 2020-12-31 | 0.03 | 0.11 | 0.05 | 0.02 | 0.10 |
| 2020-09-30 | 0.04 | 0.13 | 0.05 | 0.03 | 0.10 |
| 2020-06-30 | 0.04 | 0.13 | 0.05 | 0.06 | 0.11 |
Gross Margins
- The gross margin for CVS Health Corporation as of 30 June 2025 is 0.14.
- The net margin for CVS Health Corporation as of 30 June 2025 is 0.01.
- The operating margin for CVS Health Corporation as of 30 June 2025 is 0.03.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 0.14 | 0.01 | 0.03 |
| 2025-03-31 | 0.13 | 0.01 | 0.02 |
| 2024-12-31 | 0.14 | 0.01 | 0.03 |
| 2024-09-30 | 0.14 | 0.02 | 0.03 |
| 2024-06-30 | 0.15 | 0.02 | 0.03 |
| 2024-03-31 | 0.15 | 0.02 | 0.04 |
| 2023-12-31 | 0.15 | 0.02 | 0.04 |
| 2023-09-30 | 0.16 | 0.01 | 0.04 |
| 2023-06-30 | 0.16 | 0.01 | 0.04 |
| 2023-03-31 | 0.17 | 0.01 | 0.05 |
| 2022-12-31 | 0.17 | 0.01 | 0.05 |
| 2022-09-30 | 0.17 | 0.01 | 0.05 |
| 2022-06-30 | 0.17 | 0.03 | 0.05 |
| 2022-03-31 | 0.17 | 0.03 | 0.05 |
| 2021-12-31 | 0.17 | 0.03 | 0.05 |
| 2021-09-30 | 0.17 | 0.03 | 0.05 |
| 2021-06-30 | 0.17 | 0.03 | 0.05 |
| 2021-03-31 | 0.18 | 0.03 | 0.05 |
| 2020-12-31 | 0.18 | 0.03 | 0.05 |
| 2020-09-30 | 0.18 | 0.03 | 0.05 |
| 2020-06-30 | 0.18 | 0.03 | 0.05 |
Identifiers and Descriptors
| Central Index Key (CIK) | 64803 |
Industry Groups
| SIC 5912 - Drug Stores and Proprietary Stores |
